Whitestone has acquired a 69% majority stake in Lambda-X Ophtalmics for €5.3 million, significantly expanding its portfolio in the growing ophthalmic metrology sector.
Target Company Overview
Whitestone, listed on the Brussels Stock Exchange, has recently acquired a 69% majority stake in Lambda-X Ophtalmics, a global leader in lens metrology, for €5.3 million. With this acquisition, Whitestone's net assets exceed €100 million. Founded in 2012 by former executives of Compagnie Nationale à Portefeuille, Whitestone made its market entry by acquiring Evadix in 2021.
Lambda-X Ophtalmics, based in Nivelles, Belgium, specializes in the high-performance optical systems for both industrial and space applications. Initially part of Lambda-X, which originated as a spin-off from ULB in 1996, Lambda-X Ophtalmics entered the ophthalmic metrology sector around 15 years ago, focusing on intraocular and contact lens control. The company is known for its unique technology that originates from space applications and is recognized as one of the world leaders in this field.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Belgium
The ophthalmic device sector in Belgium is characterized by significant innovation and a commitment to high-quality manufacturing. As the population ages, the demand for advanced eye care technolo
Similar Deals
Whitestone
invested in
Lambda-X Ophtalmics
in 2024
in a Buyout deal
Disclosed details
Transaction Size: $5M
Revenue: $6M